We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
MAX
SECTIONS
  • TISSUE
  • BRAIN
  • SINGLE CELL TYPE
  • TISSUE CELL TYPE
  • PATHOLOGY
  • DISEASE
  • IMMUNE CELL
  • BLOOD PROTEIN
  • SUBCELLULAR
  • CELL LINE
  • STRUCTURE
  • METABOLIC
ABOUT
  • INTRODUCTION
  • HISTORY
  • ORGANIZATION
  • PUBLICATIONS
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • ACKNOWLEDGMENTS
  • CONTACT
NEWS
  • NEWS ARTICLES
  • PRESS ROOM
LEARN
  • DICTIONARY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
  • METHODS
  • EDUCATIONAL VIDEOS
DATA
  • DOWNLOADABLE DATA
  • PUBLICATION DATA
  • RELEASE HISTORY
  • SARS-COV-2
HELP
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • HELP & FAQ
  • PRIVACY STATEMENT
  • LICENCE & CITATION
Fields »
Search result

Field
Term
Gene name
Class
Subclass
Class
Keyword
Chromosome
External id
Tissue
Cell type
Expression
Patient ID
Tissue
Category
Cluster
Reliability
Brain region
Category
Brain region
Category
Brain region
Category
Reliability
Cell type
Category
Cluster
Tissue
Cell type
Enrichment
Cancer
Prognosis
Cancer
Category
Cell type
Category
Cell lineage
Category
Cluster
Annotation
Disease
Location
Searches
Location
Cell line
Type
Phase
Reliability
Cancer type
Category
Cluster
Pathway
Category
Score
Score
Score
Validation
Validation
Validation
Validation
Antibodies
Protein structure
In atlas
Column


  • SUMMARY

  • TISSUE

  • BRAIN

  • SINGLE CELL

  • TISSUE CELL

  • PATHOLOGY

  • DISEASE

  • IMMUNE

  • BLOOD

  • SUBCELL

  • CELL LINE

  • STRUCTURE

  • METABOLIC

  • MAX
PROTEIN STRUCTURE
ANTIBODIES
AND
VALIDATION
Protein structures
GENERAL INFORMATIONi

General description of the gene and the encoded protein(s) using information from HGNC and Ensembl, as well as predictions made by the Human Protein Atlas project.

Gene namei

Official gene symbol, which is typically a short form of the gene name, according to HGNC.

MAX
Synonyms bHLHd4, bHLHd5, bHLHd6, bHLHd7, bHLHd8
Gene descriptioni

Full gene name according to HGNC.

MYC associated factor X
Protein classi

Assigned HPA protein class(es) for the encoded protein(s).

Read more
Cancer-related genes
Disease related genes
Human disease related genes
Transcription factors
Predicted locationi

All transcripts of all genes have been analyzed regarding the location(s) of corresponding protein based on prediction methods for signal peptides and transmembrane regions.

  • Genes with at least one transcript predicted to encode a secreted protein, according to prediction methods or to UniProt location data, have been further annotated and classified with the aim to determine if the corresponding protein(s) are secreted or actually retained in intracellular locations or membrane-attached.

  • Remaining genes, with no transcript predicted to encode a secreted protein, will be assigned the prediction-based location(s).

The annotated location overrules the predicted location, so that a gene encoding a predicted secreted protein that has been annotated as intracellular will have intracellular as the final location.

Read more
Intracellular
Protein evidence Evidence at protein level (all genes)
GENE INFORMATIONi

Gene information from Ensembl and Entrez, as well as links to available gene identifiers are displayed here. Information was retrieved from Ensembl if not indicated otherwise.

Chromosome 14
Cytoband q23.3
Chromosome location (bp) 65006174 - 65102695
Number of transcriptsi

Number of protein-coding transcripts from the gene as defined by Ensembl.

14
Ensembl ENSG00000125952 (version 103.38)
Entrez gene 4149
HGNC HGNC:6913
UniProt P61244 (UniProt - Evidence at protein level)
neXtProt NX_P61244
Antibodypedia MAX antibodies


PROTEIN STRUCTUREi

The Structure section provides predicted structures from the Alphafold protein structure database and available experimental structures from Protein Data Bank (PDB).

In the Structure drop-down menu all experimental structures from PDB are available for selection and display. The structures are displayed using the NGL Viewer and can be zoomed-in and rotated either manually or by checking the Autorotate box. The Color scheme can be selected to show the residue index, chain name or confidence score (as B-factors and pLDDT score for experimental and predicted structures, respectively). The positions for available antigen sequences in the structure are shown if Antigens is turned to ON, and the Variants slider can be used to show the positions of clinical and population variants.https://github.com/nglviewer/ngl

Read more

Predicted


Description: Structure prediction from Alphafold project. Structure version 2

# Chains: 1      # Clinical variants: 1      # Population variants: 59

Antigens:

Off
On

Variants:

Off
Clinical
Population

Color scheme:

Confidence
Residue index
Chain name

Autorotate:

Off
On



PROTEIN BROWSERi

The protein browser displays the antigen location on the target protein(s) and the features of the target protein. The tabs at the top of the protein view section can be used to switch between the different splice variants to which an antigen has been mapped.

At the top of the view, the position of the antigen (identified by the corresponding HPA identifier) is shown as a green bar. A yellow triangle on the bar indicates a <100% sequence identity to the protein target.

Below the antigens, the maximum percent sequence identity of the protein to all other proteins from other human genes is displayed, using a sliding window of 10 aa residues (HsID 10) or 50 aa residues (HsID 50). The region with the lowest possible identity is always selected for antigen design, with a maximum identity of 60% allowed for designing a single-target antigen (read more).

The curve in blue displays the predicted antigenicity i.e. the tendency for different regions of the protein to generate an immune response, with peak regions being predicted to be more antigenic.The curve shows average values based on a sliding window approach using an in-house propensity scale. (read more).

If a signal peptide is predicted by a majority of the signal peptide predictors SPOCTOPUS, SignalP 4.0, and Phobius (turquoise) and/or transmembrane regions (orange) are predicted by MDM, these are displayed.

Low complexity regions are shown in yellow and InterPro regions in green. Common (purple) and unique (grey) regions between different splice variants of the gene are also displayed (read more), and at the bottom of the protein view is the protein scale.
«
MAX-201
MAX-202
MAX-203
MAX-204
MAX-205
MAX-210
MAX-211
MAX-212
MAX-213
MAX-215
MAX-216
MAX-217
MAX-218
MAX-219
»


PROTEIN INFORMATIONi

The protein information section displays alternative protein-coding transcripts (splice variants) encoded by this gene according to the Ensembl database.

The ENSP identifier links to the Ensembl website protein summary, while the ENST identifier links to the Ensembl website transcript summary for the selected splice variant. The data in the UniProt column can be expanded to show links to all matching UniProt identifiers for this protein.

The protein classes assigned to this protein are shown if expanding the data in the protein class column. Parent protein classes are in bold font and subclasses are listed under the parent class.

The Gene Ontology terms assigned to this protein are listed if expanding the Gene ontology column. The length of the protein (amino acid residues according to Ensembl), molecular mass (kDalton), predicted signal peptide (according to a majority of the signal peptide predictors SPOCTOPUS, SignalP 4.0, and Phobius) and the number of predicted transmembrane region(s) (according to MDM) are also reported.
Splice variant UniProt Protein class Gene ontology Length & mass Signal peptide
(predicted)
Transmembrane regions
(predicted)
MAX-201
ENSP00000246163
ENST00000246163
P61244 [Direct mapping]
Protein max
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Transcription factors
   Basic domains
Cancer-related genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
Disease related genes
Human disease related genes
   Cancers
   Cancers of endocrine organs
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000082 [G1/S transition of mitotic cell cycle]
GO:0000122 [negative regulation of transcription by RNA polymerase II]
GO:0000785 [chromatin]
GO:0000977 [RNA polymerase II transcription regulatory region sequence-specific DNA binding]
GO:0000981 [DNA-binding transcription factor activity, RNA polymerase II-specific]
GO:0001227 [DNA-binding transcription repressor activity, RNA polymerase II-specific]
GO:0003677 [DNA binding]
GO:0003700 [DNA-binding transcription factor activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0006357 [regulation of transcription by RNA polymerase II]
GO:0030425 [dendrite]
GO:0032993 [protein-DNA complex]
GO:0042995 [cell projection]
GO:0045944 [positive regulation of transcription by RNA polymerase II]
GO:0046983 [protein dimerization activity]
GO:0070317 [negative regulation of G0 to G1 transition]
GO:0070888 [E-box binding]
GO:0071339 [MLL1 complex]
GO:0090575 [RNA polymerase II transcription regulator complex]
GO:1990837 [sequence-specific double-stranded DNA binding]
Show all
96 aa
11.5 kDa
No 0
MAX-202
ENSP00000284165
ENST00000284165
P61244 [Direct mapping]
Protein max
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Transcription factors
   Basic domains
Cancer-related genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
Disease related genes
Human disease related genes
   Cancers
   Cancers of endocrine organs
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000082 [G1/S transition of mitotic cell cycle]
GO:0000122 [negative regulation of transcription by RNA polymerase II]
GO:0000785 [chromatin]
GO:0000977 [RNA polymerase II transcription regulatory region sequence-specific DNA binding]
GO:0000981 [DNA-binding transcription factor activity, RNA polymerase II-specific]
GO:0001227 [DNA-binding transcription repressor activity, RNA polymerase II-specific]
GO:0003677 [DNA binding]
GO:0003700 [DNA-binding transcription factor activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0006357 [regulation of transcription by RNA polymerase II]
GO:0030425 [dendrite]
GO:0032993 [protein-DNA complex]
GO:0042995 [cell projection]
GO:0045944 [positive regulation of transcription by RNA polymerase II]
GO:0046983 [protein dimerization activity]
GO:0070317 [negative regulation of G0 to G1 transition]
GO:0070888 [E-box binding]
GO:0071339 [MLL1 complex]
GO:0090575 [RNA polymerase II transcription regulator complex]
GO:1990837 [sequence-specific double-stranded DNA binding]
Show all
134 aa
15.4 kDa
No 0
MAX-203
ENSP00000342482
ENST00000341653
P61244 [Direct mapping]
Protein max
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Transcription factors
   Basic domains
Cancer-related genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
Disease related genes
Human disease related genes
   Cancers
   Cancers of endocrine organs
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000082 [G1/S transition of mitotic cell cycle]
GO:0000122 [negative regulation of transcription by RNA polymerase II]
GO:0000785 [chromatin]
GO:0000977 [RNA polymerase II transcription regulatory region sequence-specific DNA binding]
GO:0000981 [DNA-binding transcription factor activity, RNA polymerase II-specific]
GO:0001227 [DNA-binding transcription repressor activity, RNA polymerase II-specific]
GO:0003677 [DNA binding]
GO:0003700 [DNA-binding transcription factor activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0006357 [regulation of transcription by RNA polymerase II]
GO:0030425 [dendrite]
GO:0032993 [protein-DNA complex]
GO:0042995 [cell projection]
GO:0045944 [positive regulation of transcription by RNA polymerase II]
GO:0046983 [protein dimerization activity]
GO:0070317 [negative regulation of G0 to G1 transition]
GO:0070888 [E-box binding]
GO:0071339 [MLL1 complex]
GO:0090575 [RNA polymerase II transcription regulator complex]
GO:1990837 [sequence-specific double-stranded DNA binding]
Show all
83 aa
9.6 kDa
No 0
MAX-204
ENSP00000351175
ENST00000358402
P61244 [Direct mapping]
Protein max
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Transcription factors
   Basic domains
Cancer-related genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
Disease related genes
Human disease related genes
   Cancers
   Cancers of endocrine organs
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000082 [G1/S transition of mitotic cell cycle]
GO:0000122 [negative regulation of transcription by RNA polymerase II]
GO:0000785 [chromatin]
GO:0000977 [RNA polymerase II transcription regulatory region sequence-specific DNA binding]
GO:0000981 [DNA-binding transcription factor activity, RNA polymerase II-specific]
GO:0001227 [DNA-binding transcription repressor activity, RNA polymerase II-specific]
GO:0003677 [DNA binding]
GO:0003700 [DNA-binding transcription factor activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0006357 [regulation of transcription by RNA polymerase II]
GO:0030425 [dendrite]
GO:0032993 [protein-DNA complex]
GO:0042995 [cell projection]
GO:0045944 [positive regulation of transcription by RNA polymerase II]
GO:0046983 [protein dimerization activity]
GO:0070317 [negative regulation of G0 to G1 transition]
GO:0070888 [E-box binding]
GO:0071339 [MLL1 complex]
GO:0090575 [RNA polymerase II transcription regulator complex]
GO:1990837 [sequence-specific double-stranded DNA binding]
Show all
151 aa
17.2 kDa
No 0
MAX-205
ENSP00000351490
ENST00000358664
P61244 [Direct mapping]
Protein max
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Transcription factors
   Basic domains
Cancer-related genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
Disease related genes
Human disease related genes
   Cancers
   Cancers of endocrine organs
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000082 [G1/S transition of mitotic cell cycle]
GO:0000122 [negative regulation of transcription by RNA polymerase II]
GO:0000785 [chromatin]
GO:0000977 [RNA polymerase II transcription regulatory region sequence-specific DNA binding]
GO:0000978 [RNA polymerase II cis-regulatory region sequence-specific DNA binding]
GO:0000981 [DNA-binding transcription factor activity, RNA polymerase II-specific]
GO:0001227 [DNA-binding transcription repressor activity, RNA polymerase II-specific]
GO:0003677 [DNA binding]
GO:0003700 [DNA-binding transcription factor activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005737 [cytoplasm]
GO:0006355 [regulation of transcription, DNA-templated]
GO:0006357 [regulation of transcription by RNA polymerase II]
GO:0009267 [cellular response to starvation]
GO:0010243 [response to organonitrogen compound]
GO:0010629 [negative regulation of gene expression]
GO:0016605 [PML body]
GO:0030425 [dendrite]
GO:0032868 [response to insulin]
GO:0032993 [protein-DNA complex]
GO:0042802 [identical protein binding]
GO:0042995 [cell projection]
GO:0043565 [sequence-specific DNA binding]
GO:0044877 [protein-containing complex binding]
GO:0045944 [positive regulation of transcription by RNA polymerase II]
GO:0046983 [protein dimerization activity]
GO:0048678 [response to axon injury]
GO:0051402 [neuron apoptotic process]
GO:0060041 [retina development in camera-type eye]
GO:0065003 [protein-containing complex assembly]
GO:0070317 [negative regulation of G0 to G1 transition]
GO:0070888 [E-box binding]
GO:0071339 [MLL1 complex]
GO:0071375 [cellular response to peptide hormone stimulus]
GO:0090575 [RNA polymerase II transcription regulator complex]
GO:1990837 [sequence-specific double-stranded DNA binding]
Show all
160 aa
18.3 kDa
No 0
MAX-210
ENSP00000452405
ENST00000555419
G3V5L1 [Direct mapping]
Protein max
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
Human disease related genes
   Cancers
   Cancers of endocrine organs
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0003677 [DNA binding]
GO:0005634 [nucleus]
GO:0046983 [protein dimerization activity]
GO:0071339 [MLL1 complex]
GO:0090575 [RNA polymerase II transcription regulator complex]
Show all
124 aa
14.1 kDa
No 0
MAX-211
ENSP00000452286
ENST00000555667
Q6V3B1 [Direct mapping]
Myc-associated factor X
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
Human disease related genes
   Cancers
   Cancers of endocrine organs
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0003677 [DNA binding]
GO:0005634 [nucleus]
GO:0046983 [protein dimerization activity]
GO:0071339 [MLL1 complex]
GO:0090575 [RNA polymerase II transcription regulator complex]
Show all
94 aa
11 kDa
No 0
MAX-212
ENSP00000450763
ENST00000555932
G3V2N4 [Direct mapping]
Protein max
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
Human disease related genes
   Cancers
   Cancers of endocrine organs
Protein evidence (Ezkurdia et al 2014)
Show all
82 aa
8.7 kDa
No 0
MAX-213
ENSP00000450818
ENST00000556443
G3V2R5 [Direct mapping]
Myc-associated factor X
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
Human disease related genes
   Cancers
   Cancers of endocrine organs
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0003677 [DNA binding]
GO:0005634 [nucleus]
GO:0046983 [protein dimerization activity]
GO:0071339 [MLL1 complex]
GO:0090575 [RNA polymerase II transcription regulator complex]
Show all
125 aa
14.3 kDa
No 0
MAX-215
ENSP00000452206
ENST00000556892
G3V570 [Direct mapping]
Protein max
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
Human disease related genes
   Cancers
   Cancers of endocrine organs
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0003677 [DNA binding]
GO:0005634 [nucleus]
GO:0071339 [MLL1 complex]
GO:0090575 [RNA polymerase II transcription regulator complex]
Show all
43 aa
5.1 kDa
No 0
MAX-216
ENSP00000452378
ENST00000556979
P61244 [Direct mapping]
Protein max
A0A024R682 [Target identity:100%; Query identity:100%]
Myc-associated factor X
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Transcription factors
   Basic domains
Cancer-related genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
Disease related genes
Human disease related genes
   Cancers
   Cancers of endocrine organs
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000082 [G1/S transition of mitotic cell cycle]
GO:0000122 [negative regulation of transcription by RNA polymerase II]
GO:0000785 [chromatin]
GO:0000977 [RNA polymerase II transcription regulatory region sequence-specific DNA binding]
GO:0000981 [DNA-binding transcription factor activity, RNA polymerase II-specific]
GO:0001227 [DNA-binding transcription repressor activity, RNA polymerase II-specific]
GO:0003677 [DNA binding]
GO:0003700 [DNA-binding transcription factor activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0006357 [regulation of transcription by RNA polymerase II]
GO:0030425 [dendrite]
GO:0032993 [protein-DNA complex]
GO:0042995 [cell projection]
GO:0045944 [positive regulation of transcription by RNA polymerase II]
GO:0046983 [protein dimerization activity]
GO:0070317 [negative regulation of G0 to G1 transition]
GO:0070888 [E-box binding]
GO:0071339 [MLL1 complex]
GO:0090575 [RNA polymerase II transcription regulator complex]
GO:1990837 [sequence-specific double-stranded DNA binding]
Show all
103 aa
12.1 kDa
No 0
MAX-217
ENSP00000450955
ENST00000557277
G3V302 [Direct mapping]
Protein max
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
Human disease related genes
   Cancers
   Cancers of endocrine organs
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0003677 [DNA binding]
GO:0005634 [nucleus]
GO:0071339 [MLL1 complex]
GO:0090575 [RNA polymerase II transcription regulator complex]
Show all
97 aa
10.7 kDa
No 0
MAX-218
ENSP00000452197
ENST00000557746
G3V563 [Direct mapping]
Myc-associated factor X
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
Human disease related genes
   Cancers
   Cancers of endocrine organs
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0003677 [DNA binding]
GO:0005634 [nucleus]
GO:0046983 [protein dimerization activity]
GO:0071339 [MLL1 complex]
GO:0090575 [RNA polymerase II transcription regulator complex]
Show all
121 aa
14 kDa
No 0
MAX-219
ENSP00000480127
ENST00000618858
P61244 [Direct mapping]
Protein max
A0A024R682 [Target identity:100%; Query identity:100%]
Myc-associated factor X
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Transcription factors
   Basic domains
Cancer-related genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
Disease related genes
Human disease related genes
   Cancers
   Cancers of endocrine organs
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000082 [G1/S transition of mitotic cell cycle]
GO:0000122 [negative regulation of transcription by RNA polymerase II]
GO:0000785 [chromatin]
GO:0000977 [RNA polymerase II transcription regulatory region sequence-specific DNA binding]
GO:0000981 [DNA-binding transcription factor activity, RNA polymerase II-specific]
GO:0001227 [DNA-binding transcription repressor activity, RNA polymerase II-specific]
GO:0003677 [DNA binding]
GO:0003700 [DNA-binding transcription factor activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0006357 [regulation of transcription by RNA polymerase II]
GO:0030425 [dendrite]
GO:0032993 [protein-DNA complex]
GO:0042995 [cell projection]
GO:0045944 [positive regulation of transcription by RNA polymerase II]
GO:0046983 [protein dimerization activity]
GO:0070317 [negative regulation of G0 to G1 transition]
GO:0070888 [E-box binding]
GO:0071339 [MLL1 complex]
GO:0090575 [RNA polymerase II transcription regulator complex]
GO:1990837 [sequence-specific double-stranded DNA binding]
Show all
103 aa
12.1 kDa
No 0

Contact

  • NEWS ARTICLES
  • PRESS ROOM
  • contact@proteinatlas.org

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS

The Human Protein Atlas

  • DOWNLOADABLE DATA
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg Foundation.